Skip to main content
Top

Drugs

Issue 13/2008

Content (13 Articles)

HMG-CoA Reductase Inhibitors

  • Current Opinion

Pinar H. Kodaman, Antoni J. Duleba

Local Treatment of Vulvovaginal Candidosis

  • Therapy In Practice

José das Neves, Eugénia Pinto, Branca Teixeira, Gustavo Dias, Patrocínia Rocha, Teresa Cunha, Bárbara Santos, Maria H. Amaral, Maria F. Bahia

Approved and Investigational Uses of Modafinil

  • Review Article

Raminder Kumar

Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia

  • Original Research Article

George Dimopoulos, Dimitrios K. Matthaiou, Drosos E. Karageorgopoulos, Alexandros P. Grammatikos, Zoe Athanassa, Matthew E. Falagas

Budesonide/Formoterol Pressurized Metered-Dose Inhaler

  • Adis Drug Profile

Katherine A. Lyseng-Williamson, Dene Simpson

Febuxostat

  • Adis Drug Profile

Philip I. Hair, Paul L. McCormack, Gillian M. Keating

Febuxostat

  • Adis Drug Profile

N. Lawrence Edwards

Febuxostat

  • Adis Drug Profile

Naomi Schlesinger

Febuxostat

  • Adis Drug Profile

H. Ralph Schumacher Jr, Lan X. Chen

Telmisartan/Hydrochlorothiazide

  • Adis Drug Evaluation

Greg L. Plosker, William B. White

Ramelteon

  • Adis Drug Evaluation

Dene Simpson, Monique P. Curran

Anaesthetic Drugs and Defibrillation Threshold Testing

  • Correspondence

Sony Jacob, Aril E. Abraham, George Mckelvey

The Authors’ Reply

  • Correspondence

Anna Legreid Dopp, John M. Miller, James E. Tisdale

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images